X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (880) 880
Publication (29) 29
Magazine Article (4) 4
Book Review (3) 3
Book / eBook (2) 2
Book Chapter (2) 2
Newspaper Article (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (533) 533
razoxane - therapeutic use (409) 409
animals (364) 364
female (309) 309
razoxane - pharmacology (293) 293
male (278) 278
oncology (228) 228
mice (153) 153
razoxane - administration & dosage (152) 152
doxorubicin (151) 151
adult (143) 143
dexrazoxane (143) 143
pharmacology & pharmacy (141) 141
rats (128) 128
piperazines - therapeutic use (123) 123
middle aged (121) 121
heart - drug effects (113) 113
icrf-187 (107) 107
aged (106) 106
razoxane - adverse effects (106) 106
antibiotics, antineoplastic - adverse effects (99) 99
cardiotoxicity (99) 99
razoxane (95) 95
antineoplastic agents - pharmacology (93) 93
doxorubicin - adverse effects (93) 93
antineoplastic agents - therapeutic use (92) 92
index medicus (90) 90
cardiovascular agents - therapeutic use (87) 87
piperazines - pharmacology (86) 86
dose-response relationship, drug (82) 82
neoplasms - drug therapy (81) 81
antineoplastic agents - adverse effects (79) 79
chemotherapy (78) 78
adriamycin (74) 74
child (74) 74
heart diseases - chemically induced (72) 72
anthracyclines - adverse effects (70) 70
time factors (69) 69
razoxane - analogs & derivatives (66) 66
cancer (65) 65
cardiomyopathies - chemically induced (65) 65
heart diseases - prevention & control (65) 65
anthracyclines (64) 64
doxorubicin - toxicity (64) 64
clinical trials as topic (63) 63
adolescent (62) 62
advanced breast-cancer (62) 62
topoisomerase ii inhibitors (62) 62
breast neoplasms - drug therapy (61) 61
doxorubicin - administration & dosage (58) 58
toxicity (56) 56
antineoplastic combined chemotherapy protocols - therapeutic use (54) 54
cardiomyopathies - prevention & control (52) 52
drug therapy, combination (47) 47
biochemistry & molecular biology (46) 46
drug administration schedule (46) 46
drug evaluation (46) 46
treatment outcome (46) 46
cardiomyopathy (44) 44
risk factors (44) 44
cardiovascular agents - pharmacology (43) 43
iron (42) 42
doxorubicin - pharmacology (41) 41
daunorubicin (40) 40
neoplasm metastasis (40) 40
rats, sprague-dawley (40) 40
anthracycline (39) 39
apoptosis (39) 39
cell line (39) 39
doxorubicin - therapeutic use (39) 39
cell division - drug effects (38) 38
combined modality therapy (38) 38
dna topoisomerases, type ii - metabolism (38) 38
cardiac toxicity (37) 37
cell survival - drug effects (37) 37
antibiotics, antineoplastic - administration & dosage (36) 36
antineoplastic combined chemotherapy protocols - adverse effects (36) 36
heart (36) 36
razoxane - chemistry (35) 35
antineoplastic agents - administration & dosage (34) 34
child, preschool (34) 34
cricetinae (34) 34
hematology (34) 34
hydrolysis (34) 34
myocardium - pathology (34) 34
-1,2-bis (33) 33
drug interactions (33) 33
lung neoplasms - drug therapy (33) 33
antibiotics, antineoplastic - therapeutic use (32) 32
antibiotics, antineoplastic - toxicity (32) 32
apoptosis - drug effects (32) 32
cells, cultured (32) 32
cytotoxicity (32) 32
oxidative stress (32) 32
razoxane - toxicity (32) 32
breast-cancer (31) 31
chelating agents - therapeutic use (31) 31
enzyme inhibitors - pharmacology (31) 31
kinetics (31) 31
toxicology (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (811) 811
German (25) 25
Chinese (18) 18
Russian (12) 12
Italian (6) 6
Polish (6) 6
Czech (4) 4
French (2) 2
Hungarian (2) 2
Japanese (2) 2
Dutch (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antioxidants & Redox Signaling, ISSN 1523-0864, 03/2013, Volume 18, Issue 8, pp. 899 - 929
Significance: Anthracyclines (doxorubicin, daunorubicin, or epirubicin) rank among the most effective anticancer drugs, but their clinical usefulness is... 
Forum Review Articles | DOXORUBICIN-INDUCED CARDIOTOXICITY | ADVANCED BREAST-CANCER | SPONTANEOUSLY HYPERTENSIVE-RATS | MANGANESE SUPEROXIDE-DISMUTASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ADRIAMYCIN-INDUCED CARDIOMYOPATHY | ACUTE LYMPHOBLASTIC-LEUKEMIA | ENDOCRINOLOGY & METABOLISM | SALICYLALDEHYDE ISONICOTINOYL HYDRAZONE | MITOCHONDRIAL CALCIUM HOMEOSTASIS | CONGESTIVE-HEART-FAILURE | FREE-RADICAL FORMATION | Anthracyclines - adverse effects | Reactive Oxygen Species - metabolism | Antioxidants - chemistry | Oxidative Stress | Humans | Metals - adverse effects | Razoxane - pharmacology | Anthracyclines - pharmacology | Antineoplastic Agents - adverse effects | Cardiotonic Agents - adverse effects | Myocardium - metabolism | Antineoplastic Agents - pharmacology | Razoxane - chemistry | Chelating Agents - adverse effects | Anthracyclines - chemistry | Oxidation-Reduction | Signal Transduction | Chelating Agents - chemistry | Cardiotonic Agents - chemistry | Antioxidants - pharmacology | Cardiotonic Agents - pharmacology | Chelating Agents - pharmacology | Antineoplastic Agents - chemistry | Razoxane - adverse effects | Heart - drug effects | Complications and side effects | Oxidative stress | Anthracyclines | Oxidation-reduction reaction | Chemical reactions | Dosage and administration | Research | Index Medicus | Forum Review
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2007, Volume 18, Issue 3, pp. 546 - 550
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 10, p. e0165854
[This corrects the article DOI: 10.1371/journal.pone.0163703.]. 
Zebrafish | Germ cells | Epirubicin | Razoxane
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 07/2007, Volume 151, Issue 6, pp. 771 - 778
Journal Article